Keyphrases
BRAF Inhibitor (BRAFi)
20%
BRAF-mutant Melanoma
40%
CA Model
20%
Combination Synergy
20%
Combination Therapy
20%
Complex Disease
20%
Complex Interactions
20%
Computational Approach
20%
Computational Methods
20%
Connectivity Map
20%
Discovery Approach
20%
Disease Network
20%
Drug Analysis
20%
Drug Combination
100%
Drug Combination Prediction
20%
Drug Discovery
20%
Drug Interactions
20%
Drug Target
20%
Drug-treated
20%
First-line Therapy
20%
Gene Expression
100%
Gene Expression Data
20%
Gene mutation
20%
Gene Network
100%
Genomic Subtyping
100%
High-throughput Screening
20%
In Vivo Model
20%
Large Matrices
20%
Malignant Melanoma
20%
Melanoma
20%
Melanoma Cells
20%
Melanoma Genomics
100%
Mining Method
100%
Model Complex
20%
Mutation Data
20%
Network Centrality Analysis
20%
Network Connectivity
20%
Network Mining
100%
Novel Treatments
20%
Pathophysiology
20%
Potential Drugs
20%
Precision Medicine
20%
Publicly Available
20%
Relevant Protein
20%
Retinoic Acid Receptor Agonist
20%
RNA-seq Analysis
20%
Screening Study
20%
Synergistic Drug Combination
100%
Systems Biology
20%
Target Pathways
20%
Traditional Drugs
20%
Transcriptomics
20%
Tretinoin
20%
Vemurafenib
20%
Biochemistry, Genetics and Molecular Biology
Gene Expression
100%
Gene Mutation
25%
Genomics
100%
High Throughput Screening
25%
Receptor Agonists
25%
Retinoic Acid Receptor
25%
RNA Sequence
25%
Transcriptomics
25%
Tretinoin
25%
Vemurafenib
25%
Wild Type
25%
Pharmacology, Toxicology and Pharmaceutical Science
Combination Drug
100%
Combination Therapy
12%
Disease Model
12%
Diseases
50%
Drug Discovery
12%
Drug Screening
12%
Melanoma
100%
Pathophysiology
12%
Receptor Agonist
12%
Retinoic Acid
12%
Retinoic Acid Receptor
12%
RNA-Sequencing
12%
Vemurafenib
12%